142 related articles for article (PubMed ID: 22576132)
1. HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water-soluble micelle as anticancer agent: In vitro and in vivo anticancer effect.
Fang J; Greish K; Qin H; Liao L; Nakamura H; Takeya M; Maeda H
Eur J Pharm Biopharm; 2012 Aug; 81(3):540-7. PubMed ID: 22576132
[TBL] [Abstract][Full Text] [Related]
2. Styrene-maleic acid-copolymer conjugated zinc protoporphyrin as a candidate drug for tumor-targeted therapy and imaging.
Fang J; Tsukigawa K; Liao L; Yin H; Eguchi K; Maeda H
J Drug Target; 2016; 24(5):399-407. PubMed ID: 26302870
[TBL] [Abstract][Full Text] [Related]
3. Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles.
Nakamura H; Fang J; Gahininath B; Tsukigawa K; Maeda H
J Control Release; 2011 Nov; 155(3):367-75. PubMed ID: 21600248
[TBL] [Abstract][Full Text] [Related]
4. The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cells.
Herrmann H; Kneidinger M; Cerny-Reiterer S; Rülicke T; Willmann M; Gleixner KV; Blatt K; Hörmann G; Peter B; Samorapoompichit P; Pickl W; Bharate GY; Mayerhofer M; Sperr WR; Maeda H; Valent P
Curr Cancer Drug Targets; 2012 Jan; 12(1):51-63. PubMed ID: 22165967
[TBL] [Abstract][Full Text] [Related]
5. High-loading nanosized micelles of copoly(styrene-maleic acid)-zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor.
Iyer AK; Greish K; Fang J; Murakami R; Maeda H
Biomaterials; 2007 Apr; 28(10):1871-81. PubMed ID: 17208294
[TBL] [Abstract][Full Text] [Related]
6. Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy.
Gleixner KV; Mayerhofer M; Vales A; Gruze A; Hörmann G; Cerny-Reiterer S; Lackner E; Hadzijusufovic E; Herrmann H; Iyer AK; Krauth MT; Pickl WF; Marian B; Panzer-Grümayer R; Sillaber C; Maeda H; Zielinski C; Valent P
Curr Cancer Drug Targets; 2009 Aug; 9(5):675-89. PubMed ID: 19508170
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.
Tsukigawa K; Liao L; Nakamura H; Fang J; Greish K; Otagiri M; Maeda H
Cancer Sci; 2015 Mar; 106(3):270-8. PubMed ID: 25529761
[TBL] [Abstract][Full Text] [Related]
8. Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia.
Cerny-Reiterer S; Meyer RA; Herrmann H; Peter B; Gleixner KV; Stefanzl G; Hadzijusufovic E; Pickl WF; Sperr WR; Melo JV; Maeda H; Jäger U; Valent P
Oncotarget; 2014 Mar; 5(5):1198-211. PubMed ID: 24681707
[TBL] [Abstract][Full Text] [Related]
9. In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor.
Fang J; Sawa T; Akaike T; Akuta T; Sahoo SK; Khaled G; Hamada A; Maeda H
Cancer Res; 2003 Jul; 63(13):3567-74. PubMed ID: 12839943
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastases.
Daruwalla J; Nikfarjam M; Greish K; Malcontenti-Wilson C; Muralidharan V; Christophi C; Maeda H
Cancer Sci; 2010 Aug; 101(8):1866-74. PubMed ID: 20579075
[TBL] [Abstract][Full Text] [Related]
11. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
Greish K; Nagamitsu A; Fang J; Maeda H
Bioconjug Chem; 2005; 16(1):230-6. PubMed ID: 15656596
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin.
Fang J; Sawa T; Akaike T; Greish K; Maeda H
Int J Cancer; 2004 Mar; 109(1):1-8. PubMed ID: 14735461
[TBL] [Abstract][Full Text] [Related]
13. Blocking heme oxygenase-1 by zinc protoporphyrin reduces tumor hypoxia-mediated VEGF release and inhibits tumor angiogenesis as a potential therapeutic agent against colorectal cancer.
Cheng CC; Guan SS; Yang HJ; Chang CC; Luo TY; Chang J; Ho AS
J Biomed Sci; 2016 Jan; 23():18. PubMed ID: 26822586
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted induction of oxystress for cancer therapy.
Fang J; Nakamura H; Iyer AK
J Drug Target; 2007; 15(7-8):475-86. PubMed ID: 17671894
[TBL] [Abstract][Full Text] [Related]
15. SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours.
Greish K; Sawa T; Fang J; Akaike T; Maeda H
J Control Release; 2004 Jun; 97(2):219-30. PubMed ID: 15196749
[TBL] [Abstract][Full Text] [Related]
16. Dual pH-sensitive oxidative stress generating micellar nanoparticles as a novel anticancer therapeutic agent.
Park S; Kwon B; Yang W; Han E; Yoo W; Kwon BM; Lee D
J Control Release; 2014 Dec; 196():19-27. PubMed ID: 25278257
[TBL] [Abstract][Full Text] [Related]
17. Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis.
Hadzijusufovic E; Rebuzzi L; Gleixner KV; Ferenc V; Peter B; Kondo R; Gruze A; Kneidinger M; Krauth MT; Mayerhofer M; Samorapoompichit P; Greish K; Iyer AK; Pickl WF; Maeda H; Willmann M; Valent P
Exp Hematol; 2008 Nov; 36(11):1461-70. PubMed ID: 18723263
[TBL] [Abstract][Full Text] [Related]
18. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
[TBL] [Abstract][Full Text] [Related]
19. Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity.
Sahoo SK; Sawa T; Fang J; Tanaka S; Miyamoto Y; Akaike T; Maeda H
Bioconjug Chem; 2002; 13(5):1031-8. PubMed ID: 12236785
[TBL] [Abstract][Full Text] [Related]
20. Effect of different chemical bonds in pegylation of zinc protoporphyrin that affects drug release, intracellular uptake, and therapeutic effect in the tumor.
Tsukigawa K; Nakamura H; Fang J; Otagiri M; Maeda H
Eur J Pharm Biopharm; 2015 Jan; 89():259-70. PubMed ID: 25527214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
